Coriolis Pharma, a globally operating service provider for R&D and GMP drug product development, R&D and GMP analytics and sterile drug product manufacturing support, has launched a U.S. entity.   U.S. customers will be served by the U.S.-based Coriolis commercial organization, which consists of business development and client project management professionals.   Coriolis is also launching two novel platform services for developability assessment and pre-formulation screening, designe...